Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on -amyloid plaque load in two transgenic APP/PS1 mouse models of Alzheimers disease
Before you panic (or double up), here's exactly what you should and shouldn't do to stay on track with your weight loss goals
Smaller Biotechs and Collaborators: Companies like Zealand Pharma, Glycadia, and others have GLP-1 analogs or co-agonists in early trials, often in partnership with larger pharma (e.g., Novo Nordisk collaboration with Zealand)
Gradual dose titration (50100 mcg increases every 35 days) produces more consistent onset timelines than abrupt dose jumps, which can trigger temporary tolerance
And if such a patient tolerated the initial 2 mg/Kg dose of methylene blue IV without difficulty, we certainly would not hesitate to begin a continuous infusion if we felt that it was required
To investigate whether this partial effect was due to an incomplete knockdown, we performed experiments in HEK293 cells with both -arrestin isoforms deleted by CRISPR-Cas9 41